NetApp Sees FY23 EPS $5.30-$5.50 Vs $6.53B Est
Full fiscal year 2023 financial outlook
The Company provided the following financial guidance for the full fiscal year 2023:
Net revenues are expected to be flat
NetApp Sees Q4 EPS $1.30-$1.40 Vs $1.43 Est.; Q4 Revenue $1.475B-$1.625B Vs $1.67B Est
Fourth quarter of fiscal year 2023 financial outlook
The Company provided the following financial guidance for the third quarter of fiscal year 2023:
Net revenues are expected
Teladoc Health Sees Q1 Revenue $610M-$625M Vs $642.43M Est; Q1 EPS ($0.55)-($0.45) Vs ($0.41) Est
Financial Outlook
Teladoc Health provides an outlook based on current market conditions and expectations and what we know today. Based on what we know today, we believe our outlook ranges
Marriott Vacations Worldwide Sees FY23 EPS $9.51-$10.30 Vs $11.6 Est
The Company expects contract sales in 2023 to grow 5% to 9% compared to the prior year and for Net income attributable to common shareholders to be $405 million to $440 million,
What’s Going On With Vertiv Holdings Stock Today?
Vertiv Holdings (NYSE: VRT) shares are trading higher despite the company reporting worse-than-expected fourth-quarter adjusted EPS and sales results.
Everbridge Shares Drop On Cautious Q1 Outlook; Registers 14% Revenue Growth In Q4 Backed By Recurring Bookings, Renewals
Everbridge, Inc (NASDAQ:EVBG) clocked a 14% revenue growth in Q3 to $117.1 million, beating the consensus of $116.2 million. Non-GAAP…
Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure
Fresenius Medical Care AG & Co (NYSE:FMS) has implemented its new operating model with two global segments: Care Enablement (Health Care…
Garmin Clocked 6% Topline Decline Due To Mixed Segmental Performance; Indicates Cautious Outlook
Garmin Ltd (NYSE: GRMN) reported a fourth-quarter FY22 revenue decline of 6% year-on-year to $1.31 billion,
Sanara MedTech Inc. Announces Unaudited Preliminary Results For Q4 And FY22; Q4 Net Revenue Of $15.3M; FY22 Net Revenue Of $45.8M
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a medical technology company focused on
Wingstop Reaffirms 3 – 5 Year Domestic Same Store Sales Growth Outlook of Mid-Single Digit
Financial Outlook
The Company is reaffirming its three- to five-year outlook of mid-single digit domestic same store sales growth. Additionally, the Company expects the following for 2023, which is a 52-week fiscal